RECRUITINGINTERVENTIONAL
Clinical Evaluation of an IGRA Test for the Diagnosis of Active and Latent Tuberculosis
About This Trial
Methodology This is a single-center study carried out as part of routine patient care. The aim of the study is to determine the performance of the 2nd generation TB-IGRA test in the diagnosis of tuberculosis.
Who May Be Eligible (Plain English)
Who May Qualify:
- Individual at least 18 years of age
- Patient presenting for treatment of tuberculosis disease
- Having undergone or benefiting from screening for tuberculosis using a medically prescribed reference IGRA test.
- Informed patient who has not expressed opposition to participating in the study.
French-speaking patient with unambiguous understanding of oral and written instructions.
Who Should NOT Join This Trial:
Persons in a period of exclusion from another study
- Pregnant, parturient or breast-feeding women;
- Person deprived of liberty by judicial or administrative decision
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Individual at least 18 years of age
* Patient presenting for treatment of tuberculosis disease
* Having undergone or benefiting from screening for tuberculosis using a medically prescribed reference IGRA test.
* Informed patient who has not expressed opposition to participating in the study.
French-speaking patient with unambiguous understanding of oral and written instructions.
Exclusion Criteria:
Persons in a period of exclusion from another study
* Pregnant, parturient or breast-feeding women;
* Person deprived of liberty by judicial or administrative decision
Treatments Being Tested
DIAGNOSTIC_TEST
test IGRA
BLOOD SAMPLES
DIAGNOSTIC_TEST
TEST QUATIFERON TB Gold Plus
BLOOD SAMPLES
Locations (1)
Assistance Publique Hopitaux de Marseille
Marseille, France